塔达拉菲尔和费纳斯特的药物-药物共成形系统,用于提高药品性能
Nagesh A Bhale1, Avvaru Subha Jahnavi1, Rahul Khemchandani1
1Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, Balanagar, Hyderabad 500 037, India.
Molecular pharmaceutics
|December 10, 2025
概括
开发了一种新的tadalafil (TDF) 和finasteride (FNS) 的同形固体形式,以提高治疗良性前列腺增生症的溶解性和生物可用性. 这种增强的药物输送系统显示出作为一种优越的治疗替代方案的前景.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 药物运输 药物运输 药物运输
背景情况:
- 塔达拉菲尔 (TDF) 和费纳斯特 (FNS) 是具有低水溶性 (BCS II类) 的药物.
- 良性前列腺增生症 (BPH) 的治疗通常涉及组合疗法.
- 由于溶解性差,现有的组合产品可能具有低于最佳的药物性能.
研究的目的:
- 开发一种新型的tadalafil和finasteride的共同形态固态形式.
- 为了提高组合药物的水溶性和溶解概况.
- 与物理混合物相比,评估同形系统的治疗潜力.
主要方法:
- 机械化学合成被用来创建TDF-FNS同形系统.
- 描述涉及粉末X射线衍射,热分析,FT-IR,SEM和3D激光扫描显微镜.
- 在SD大鼠中进行了体外溶解和体内药理动力学研究.
主要成果:
- 同形系统表现出一种独特的固态形式,具有改进的物理化学特性.
- 与物理混合物相比,观察到体外溶解率的显著提高.
- 在体内研究表明,药物动力学参数和生物可用性得到改善.
- 同形系统在加速和长期条件下表现出合理的物理稳定性.
结论:
- 开发的tadalafil-finasteride共成形系统提供了更好的溶解性,溶解性和生物可用性.
- 这种新型的固体形式为良性前列腺增生症治疗提供了一个有前途的治疗替代方案.
- 这些发现支持这种同形药物输送系统的工业应用性和潜在的临床益处.
相关概念视频
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
134
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
134
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
183
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
183
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Bioavailability Enhancement: Drug Solubility Enhancement
197
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
197
Factors Influencing Drug Absorption: Pharmaceutical Parameters
377
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
377
Prodrugs
3.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.8K


